Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.

about

CANDO and the infinite drug discovery frontier Natural killer cells inhibit oxaliplatin-resistant colorectal cancer by repressing WBSCR22 via upregulating microRNA-146b-5p.

P2860

Q28543019-91CC1B0E-6A09-4731-B3D6-870917579E5A Q55213979-CE647F45-3982-4B21-9614-1AF1CA789C66

P2860

Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.

Item

http://www.wikidata.org/entity/Q38000961

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.

@en

type

Item

label

Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.

@en

prefLabel

Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.

@en

P1476

Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.

@en

P2093

Ammad Ahmad Farooqi

http://www.w3.org/2001/XMLSchema#string

Muhammad Zahid Qureshi

http://www.w3.org/2001/XMLSchema#string

Sadia Rashid

http://www.w3.org/2001/XMLSchema#string

Sundas Fayyaz

http://www.w3.org/2001/XMLSchema#string

P2860

Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes

SIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomas

Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8+ T cells in the mouse.

Targeting cell surface β2 -microglobulin by pentameric IgM antibodies

The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.

MHC class I and class II molecules are expressed in both human and mouse prostate tumor microenvironment.

Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB.

Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.

Proteasome regulation of ULBP1 transcription.

P2888

s00005-012-0169-y

P304

191-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00005-012-0169-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009990086

http://www.w3.org/2001/XMLSchema#string

P698

22484802

http://www.w3.org/2001/XMLSchema#string

Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.

about

P2860

P2860

Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698